Drugs / ID-082
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03363984 | Nov → Dec 2017 | — | Idorsia Pharmaceuticals Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ID-082 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03363984 ↗ |
| Route | Oral | “Repeated Oral Doses of ID-082” NCT03363984 ↗ |